Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 9/20 | 0.41 |
| ▸ | CES1 | P23141 | 7/20 | 0.39 |
| ▸ | CES2 | O00748 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5004257 | 0.96 | FAAH (0.38) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL5344964 | 0.88 | MLYCD (0.37) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL7024069 | 0.82 | FAAH (0.39) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28708698 | 0.79 | MLYCD (0.33) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10890584 | 0.76 | CA12 (0.43) | CES1CES2CA12CA1CA9 | |
| SCHEMBL7704563 | 0.76 | MLYCD (0.40) | — | |
| SCHEMBL28778447 | 0.76 | FAAH (0.44) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL886851 | 0.74 | ALDH1A1 (0.44) | FAAHCES1CES2HSD17B10CA12 | |
| SCHEMBL22436624 | 0.72 | NAAA (0.43) | CES1CES2CA12CA1CA9 | |
| SCHEMBL28095555 | 0.72 | CA12 (0.40) | CES1CES2CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118763275-A | Lithium ion battery electrolyte and preparation method thereof | 合肥乾锐科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | claimed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | claimed |
| CN-118763275-A | Lithium ion battery electrolyte and preparation method thereof | 合肥乾锐科技有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118763275-A | Lithium ion battery electrolyte and preparation method thereof | 合肥乾锐科技有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-117015282-A | Method for optimizing perovskite film, perovskite film obtained by method and application of perovskite film | 极电光能有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-115494167-A | Method for realizing co-outflow of phosphorothioate oligonucleotide isomers in chromatographic analysis | 南京金斯瑞生物科技有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | disclosed |
| EP-1809300-A4 | METHOD FOR TREATING BACTERIAL INFECTIONS IN HORSES OR PIGS WITH TILMICOSIN | IDEXX LAB INC (US) | 2009-03-25 | — | — | EP | disclosed |
| US-7282487-B2 | Method for treating bacterial infections in horses or pigs with tilmicosin | IDEXX LABORATORIES (US) | 2007-10-16 | — | — | US | disclosed |
| EP-1809300-A1 | METHOD FOR TREATING BACTERIAL INFECTIONS IN HORSES OR PIGS WITH TILMICOSIN | IDEXX Laboratories Inc (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006049739-A1 | METHOD FOR TREATING BACTERIAL INFECTIONS IN HORSES OR PIGS WITH TILMICOSIN | IDEXX LABORATORIES, INC. (US) | 2006-05-11 | — | — | WO | disclosed |
| US-20060094669-A1 | Salts of lipophilic acids, such as fatty acids, diacids, polycarboxylic acids and aromatic acids in a pharmaceutically acceptable solvent to form an injectable composition that precipitates when injected into water; improved pharmacokinetics | IDEXX LABORATORIES | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094669-A1 | Salts of lipophilic acids, such as fatty acids, diacids, polycarboxylic acids and aromatic acids in a pharmaceutically acceptable solvent to form an injectable composition that precipitates when injected into water; improved pharmacokinetics | NRDC, PIGS, PPARD | FAAH 998/4885CES1 3454/4885CES2 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.